- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Solara Active Pharma Sciences Ltd (SOLA)
Solara Active Pharma Sciences Ltd stock price live, this page displays NSE SOLA stock exchange data. View the SOLA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Solara Active Pharma Sciences Ltd real time stock price chart below.
What Is the Solara Active Pharma Sciences Ltd Stock Price Today?
The Solara Active Pharma Sciences Ltd stock price today is 460.00.
What Is the Stock Symbol for Solara Active Pharma Sciences Ltd?
The stock symbol for Solara Active Pharma Sciences Ltd is ""SOLA.""
What Stock Exchange Does Solara Active Pharma Sciences Ltd Trade On?
Solara Active Pharma Sciences Ltd is listed and trades on the NSE stock exchange.
Is Solara Active Pharma Sciences Ltd a Good Stock to Buy?
Determining whether Solara Active Pharma Sciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOLA quote. (ISIN: INE624Z01016) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
What Is the Solara Active Pharma Sciences Ltd Stock Price Today?
The Solara Active Pharma Sciences Ltd stock price today is 460.00.
What Is the Stock Symbol for Solara Active Pharma Sciences Ltd?
The stock symbol for Solara Active Pharma Sciences Ltd is ""SOLA.""
What Stock Exchange Does Solara Active Pharma Sciences Ltd Trade On?
Solara Active Pharma Sciences Ltd is listed and trades on the NSE stock exchange.
Is Solara Active Pharma Sciences Ltd a Good Stock to Buy?
Determining whether Solara Active Pharma Sciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOLA quote. (ISIN: INE624Z01016) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
460.00
-2.20(-0.48%)
Closed·
Fair Value
An estimate of a Solara Active Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
450.65
463.60
52 wk Range
440.20
734.40
SOLA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Solara Active Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
450.65463.60
52 wk Range
440.20734.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SOLA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Solara Active Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Sell
Price Target
566.00
Upside
+23.04%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Solara Active Pharma Sciences Ltd Company Profile
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, anti-hyperkalaemia, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical development, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Compare SOLA to Peers and Sector
Metrics to compare | SOLA | Peers Peers - average of corresponding metrics from companies closely matching SOLA: SUVEN, 540694, IOLCP, NECLIFE, MOREPENLAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSOLAPeersSector |
|---|---|---|---|---|
P/E Ratio | −116.5x | 27.1x | −0.5x | |
PEG Ratio | −1.21 | 0.28 | 0.00 | |
Price/Book | 1.8x | 3.3x | 2.6x | |
Price / LTM Sales | 1.8x | 2.8x | 3.3x | |
Upside (Analyst Target) | 22.5% | 15.5% | 45.5% | |
Fair Value Upside | Unlock | 5.8% | 5.7% | Unlock |
Analyst Ratings
0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell
Analysts 12-Month Price Target:
Average 566.00
(+23.04% Upside)
Earnings
Latest Release
Feb 06, 2026
EPS / Forecast
-3.98 / --
Revenue / Forecast
3.49B / --
People Also Watch
FAQ
What Is the Solara Active Pharma (SOLA) Stock Price Today?
The Solara Active Pharma stock price today is 460.00 INR.
What Stock Exchange Does Solara Active Pharma Trade On?
Solara Active Pharma is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Solara Active Pharma?
The stock symbol for Solara Active Pharma is "SOLA."
What Is the Solara Active Pharma Market Cap?
As of today, Solara Active Pharma market cap is 22.21B INR.
What Is Solara Active Pharma's Earnings Per Share (TTM)?
The Solara Active Pharma EPS (TTM) is -3.52.
When Is the Next Solara Active Pharma Earnings Date?
Solara Active Pharma will release its next earnings report on May 08, 2026.
From a Technical Analysis Perspective, Is SOLA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Solara Active Pharma Stock Split?
Solara Active Pharma has split 0 times.
How Many Employees Does Solara Active Pharma Have?
Solara Active Pharma has 1775 employees.
What is the current trading status of Solara Active Pharma (SOLA)?
As of Mar 02, 2026, Solara Active Pharma (SOLA) is trading at a price of 460.00 INR, with a previous close of 462.20 INR. The stock has fluctuated within a day range of 450.65 INR to 463.60 INR, while its 52-week range spans from 440.20 INR to 734.40 INR.
What Is Solara Active Pharma (SOLA) Price Target According to Analysts?
The average 12-month price target for Solara Active Pharma is 566.00 INR, with a high estimate of 566 INR and a low estimate of 566 INR. 0 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Sell. The stock has an +23.04% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.